<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Mirum Pharmaceuticals, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Mirum Pharmaceuticals, Inc.

    Mirum Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. The company’s lead product candidate, maralixibat, is an investigational oral drug in development for progressive familial intrahepatic cholestasis (PFIC) and Alagille syndrome (ALGS). Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $345,000,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Chris Peetz
    • FOUNDED
      2018
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Luna Innovations Incorporated

    Luna Innovations Incorporated

    Luna (NASDAQ:LUNA) develops and manufactures new-generation products for the healt...

    Luna (NASDAQ:LUNA) develops and manufactures ne...

    Filing Type:    PU
    Neovasc Inc.

    Neovasc Inc.

    Neovasc is a specialty medical device company that develops, manufactures and mark...

    Neovasc is a specialty medical device company t...

    Filing Type:    PU
    Admedus Ltd.

    Admedus Ltd.

    Admedus Limited is a bio medical group. The Group commercializes tissue engineerin...

    Admedus Limited is a bio medical group. The Gro...

    Filing Type:    PR
    Lonza Group AG

    Lonza Group AG

    Lonza is an integrated solutions provider that creates value along the Healthcare ...

    Lonza is an integrated solutions provider that ...

    Filing Type:    PU
    Milestone Pharmaceuticals Inc.

    Milestone Pharmaceuticals Inc.

    We are a patient-centric, clinical-stage biopharmaceutical company dedicated to br...

    We are a patient-centric, clinical-stage biopha...

    Filing Type:    PU
    KemPharm, Inc.

    KemPharm, Inc.

    KemPharmÂŽ is a clinical-stage specialty pharmaceutical company engaged in the dis...

    KemPharmÂŽ is a clinical-stage specialty pharma...

    Filing Type:    PU
    Dicerna Pharmaceuticals, Inc.

    Dicerna Pharmaceuticals, Inc.

    Dicerna is a biopharmaceutical company focused on the discovery and development of...

    Dicerna is a biopharmaceutical company focused ...

    Filing Type:    PU
    Cyclerion Therapeutics, Inc.

    Cyclerion Therapeutics, Inc.

    Cyclerion Therapeutics is a clinical-stage biopharmaceutical company harnessing th...

    Cyclerion Therapeutics is a clinical-stage biop...

    Filing Type:    PU
    CymaBay Therapeutics Inc.

    CymaBay Therapeutics Inc.

    We are a clinical-stage biopharmaceutical company focused on developing and provid...

    We are a clinical-stage biopharmaceutical compa...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.